Literature DB >> 10910088

Depression, psychomotor retardation, negative symptoms, and memory in schizophrenia.

G Brébion1, X Amador, M Smith, D Malaspina, Z Sharif, J M Gorman.   

Abstract

OBJECTIVE: The purpose of this study was to examine the relations between depression, psychomotor retardation, and negative symptoms in schizophrenia as well as the specific contribution of each of these factors to memory impairment.
BACKGROUND: It has been suggested that depression overlaps with negative symptomatology in schizophrenia. The relation between psychomotor retardation and negative symptomatology has been unclear.
METHOD: The Hamilton Depression Rating Scale, The Positive and Negative Symptom Scale for Schizophrenia, and Scale for the Assessment of Negative Symptoms were used to assess depressive and negative symptomatology in a sample of patients with schizophrenia. Verbal memory performance was assessed by a free recall test. Two indices of processing speed were measured. Correlations among variables were computed.
RESULTS: Depression score was correlated with the avolition item from the Scale for the Assessment of Negative Symptoms and with both measures of processing speed. Negative symptomatology was unrelated to processing speed. Memory performance was correlated with depression score, slowing of processing speed, and avolition. Its correlation with depression score and processing speed remained significant when the other factors were partialled out.
CONCLUSIONS: Memory performance in schizophrenia may be affected by lack of motivation, psychomotor retardation, and depression. It is suggested that negative symptoms could be split between a volitional component linked to depression and cognitive efficiency and an emotional component unrelated to them.

Entities:  

Mesh:

Year:  2000        PMID: 10910088

Source DB:  PubMed          Journal:  Neuropsychiatry Neuropsychol Behav Neurol        ISSN: 0894-878X


  7 in total

Review 1.  rTMS strategies for the study and treatment of schizophrenia: a review.

Authors:  Arielle D Stanford; Zafar Sharif; Cheryl Corcoran; Nina Urban; Dolores Malaspina; Sarah H Lisanby
Journal:  Int J Neuropsychopharmacol       Date:  2008-02-01       Impact factor: 5.176

Review 2.  Cognition in schizophrenia.

Authors:  P D Harvey; C R Bowie; J I Friedman
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 3.  Anhedonia in schizophrenia: a review of assessment strategies.

Authors:  William P Horan; Ann M Kring; Jack J Blanchard
Journal:  Schizophr Bull       Date:  2005-10-12       Impact factor: 9.306

4.  Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia.

Authors:  Anthony P Weiss; A Eden Evins; Lindsay E Jubelt; Ruth S Barr; Donald C Goff; Tanya Logvinenko
Journal:  Psychopharmacology (Berl)       Date:  2008-06-12       Impact factor: 4.530

Review 5.  Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia.

Authors:  Athina Markou; John D Salamone; Timothy J Bussey; Adam C Mar; Daniela Brunner; Gary Gilmour; Peter Balsam
Journal:  Neurosci Biobehav Rev       Date:  2013-08-28       Impact factor: 8.989

6.  Evaluation of Visual Information Processing Speed in Depressed People.

Authors:  Mohammad Khanahmadi; Maryam Malmir; Hosein Eskandari; Tahereh Orang
Journal:  Iran J Public Health       Date:  2013-11       Impact factor: 1.429

7.  Computer Vision-Based Assessment of Motor Functioning in Schizophrenia: Use of Smartphones for Remote Measurement of Schizophrenia Symptomatology.

Authors:  Anzar Abbas; Vijay Yadav; Emma Smith; Elizabeth Ramjas; Sarah B Rutter; Caridad Benavidez; Vidya Koesmahargyo; Li Zhang; Lei Guan; Paul Rosenfield; Mercedes Perez-Rodriguez; Isaac R Galatzer-Levy
Journal:  Digit Biomark       Date:  2021-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.